[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Pages 73794-73795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28087]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Sickle Cell Disease 
Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: January 25, 2022.
    Time: 10:00 a.m. to 1:30 p.m.
    Agenda: Presentations and discussion of programs.
    Place: National Institutes of Health, Rockledge II, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Telephone Access: 1-646-828-7666 (Meeting ID: 160 241 4559) 
Passcode: 076579.
    Virtual Access: https://nih.zoomgov.com (Meeting ID: 160 241 
4559) Passcode: 076579.
    Contact Person: W. Keith Hoots, MD., Director, Division of Blood 
Diseases and Resources, National Heart, Lung, and Blood Institute, 
6705 Rockledge Drive, Bethesda, MD 20892, 301-435-0080, 
[email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases

[[Page 73795]]

and Resources Research, National Institutes of Health, HHS)

    Dated: December 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28087 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P